Atrial Fibrillation Surgery Market by Product (Cardiac Cryoablation Catheters, Cardiac Mapping System), Indication (Atrial Fibrillation (AFib), Atrial Flutter, Supraventricular Tachycardia (SVT)), End-User - Global Forecast 2024-2030

Atrial Fibrillation Surgery Market by Product (Cardiac Cryoablation Catheters, Cardiac Mapping System), Indication (Atrial Fibrillation (AFib), Atrial Flutter, Supraventricular Tachycardia (SVT)), End-User - Global Forecast 2024-2030


The Atrial Fibrillation Surgery Market size was estimated at USD 2.67 billion in 2023 and expected to reach USD 2.90 billion in 2024, at a CAGR 9.00% to reach USD 4.88 billion by 2030.

Atrial fibrillation surgery is a medical procedure to treat atrial fibrillation (AFib), an irregular and often rapid heart rate that can lead to poor blood flow, stroke, and other cardiovascular complications. Major types of atrial fibrillation surgeries include catheter ablation, surgical ablation, and left atrial appendage closure (LAAC). Over the years, there has been a significant prevalence of chronic diseases such as diabetes and hypertension, which are key risk factors for developing AFib; as a result, demand for effective AFib treatment options has surged. Innovations in minimally invasive techniques, such as catheter ablation, have significantly improved patient outcomes while reducing recovery time. However, product recalls associated with AFib surgical products, limited reimbursements for surgeries, and limited availability of surgeons to conduct the procedure also impact the market. Market players are creating affordable devices or techniques that enable greater accessibility to life-saving treatments for patients across different socioeconomic backgrounds. Continued research in areas such as artificial intelligence, robotics, and bioelectronic medicine is expected to lead to the development of innovative AFib surgery solutions that further improve patient outcomes and minimize complications.

Regional Insights

North America's atrial fibrillation surgery market observes an advancing landscape driven by the well-established healthcare infrastructure and favorable reimbursement policies to conduct surgical procedures. There have been several innovative medication products and devices approved by the U.S. Food & Drug Administration (FDA) and Health Canada in the region, portraying an improved development scenario. In Asia-Pacific, countries such as India, Japan, and China have seen a rapid increase in AFib surgeries due to a large patient pool suffering from cardiovascular diseases uptaking surgical procedures. Substantial growth in medical tourism in Asia has accelerated the number of surgeries conducted in the region, expanding the need for advanced surgical tools and devices. The production aspect of AF surgery is growing in Asia, especially in China and Japan, due to the presence of major medical device manufacturers focusing on developing cost-effective solutions to cater to the ever-growing demand for affordable healthcare services. Europe is another significant market for AFib, with many European-based companies focusing on developing innovative cardiac devices used during AF surgeries. Key players have made substantial investments in research and development activities aimed at advancing surgical technologies for treating atrial fibrillation patients effectively.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Atrial Fibrillation Surgery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
  • Rise in prevalence of atrial fibrillation in geriatric population
  • Development in preference of catheter ablation for cardiac arrhythmia treatment
  • Growing number of AF programs to enhance public awareness
Market Restraints
  • Regulatory issues associated with the devices
Market Opportunities
  • Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
  • Technological advances for catheter ablation of atrial fibrillation
Market Challenges
  • Lack of skilled professionals and awareness among the people about the surgery
Market Segmentation Analysis
  • Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
  • Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
  • End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers
Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Atrial Fibrillation Surgery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Atrial Fibrillation Surgery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care

GE HealthCare has launched CardioVisio for Atrial Fibrillation (AFib), a digital tool specifically designed to assist clinicians in visualizing longitudinal data for disease progression. With the introduction of CardioVisio, clinicians are able to save valuable time and make more informed clinical decisions, improved explainability and traceability and also it enables healthcare providers to offer personalized and evidence-based care to their patients.

Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

Biosense Webster, a global player in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, has obtained approval from the U.S. Food and Drug Administration (FDA) for multiple products in its cardiac ablation portfolio. These products are able to be utilized in conjunction with a zero fluoroscopy workflow.

Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias

Medtronic PLC has obtained the CE Mark for its Affera Mapping and Ablation System consisting of the Sphere-9 Catheter and the Affera Prism-1 Mapping Software. The approval is expected to enhance commercialization to provide mapping and ablation for atrial arrhythmias, specifically Atrial Fibrillation (AFib), a condition that affects large populations worldwide.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Atrial Fibrillation Surgery Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, Acutus Medical, Inc, Affera, Inc., AFreeze GmbH, Atrian Medical Ltd., AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cardiofocus, Inc., CathRx Ltd, Cook Group Incorporated, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Healium Medical, Japan Lifeline Co., Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Medtronic PLC, OMEICOS Therapeutics GmbH, Osypka AG, SentiAR, Inc, Siemens Healthcare GmbH, Stryker Corporation, Terumo Corporation, Thryv Therapeutics Inc., Toray Medical Co., Ltd., Vanguard AG, and Volta Medical.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
  • Cardiac Cryoablation Catheters
  • Cardiac Mapping System
  • Indication
  • Atrial Fibrillation (AFib)
  • Atrial Flutter
  • Supraventricular Tachycardia (SVT)
  • End-User
  • Cardiology
  • Multi Specialities
  • Region
  • Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom


Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in prevalence of atrial fibrillation in geriatric population
5.1.1.2. Development in preference of catheter ablation for cardiac arrhythmia treatment
5.1.1.3. Growing number of AF programs to enhance public awareness
5.1.2. Restraints
5.1.2.1. Regulatory issues associated with the devices
5.1.3. Opportunities
5.1.3.1. Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
5.1.3.2. Technological advances for catheter ablation of atrial fibrillation
5.1.4. Challenges
5.1.4.1. Lack of skilled professionals and awareness among the people about the surgery
5.2. Market Segmentation Analysis
5.2.1. Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
5.2.2. Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
5.2.3. End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Atrial Fibrillation Surgery Market, by Product
6.1. Introduction
6.2. Cardiac Cryoablation Catheters
6.3. Cardiac Mapping System
7. Atrial Fibrillation Surgery Market, by Indication
7.1. Introduction
7.2. Atrial Fibrillation (AFib)
7.3. Atrial Flutter
7.4. Supraventricular Tachycardia (SVT)
8. Atrial Fibrillation Surgery Market, by End-User
8.1. Introduction
8.2. Cardiology
8.3. Multi Specialities
9. Americas Atrial Fibrillation Surgery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Atrial Fibrillation Surgery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Atrial Fibrillation Surgery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
12.3.2. Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
12.3.3. Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings